Patents Assigned to Auckland Technology Enabling Corporation
  • Method and compositions for modifying target receptor function associated with neurological disorders
    Patent number: 7935333
    Abstract: A method of treating or preventing development of a neurological disorder has been developed wherein a subject with the disorder, or at risk of developing a disorder, is vaccinated against a brain protein or antigen. Alternatively, the antibodies can be directly administered to the individual in need of treatment thereof. Animal studies demonstrate potent efficacy in the treatment of epilepsy, stroke and cognition in animal models vaccinated against the NMDA receptor.
    Type: Grant
    Filed: February 10, 2004
    Date of Patent: May 3, 2011
    Assignee: Auckland Technology Enabling Corporation
    Inventor: Matthew J. During